HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Early diagnosis and effective treatment of pulmonary CMV infection after lung transplantation.

AbstractThe early diagnosis and effective treatment of cytomegalovirus (CMV) pneumonia remains a keystone for patient survival after lung transplantation. At present, the use of DHPG (ganciclovir sodium) opens the possibility of a potent antiviral therapy. The use of monoclonal antibodies directed to immediate early CMV antigens offers a fast method to detect the early phase of systemic or local viral replication. Five single lung and heart-lung transplant patients at high risk for CMV infection (donor, CMV-positive; recipient, CMV-negative) were monitored by cellular immunohistology for immediate early antigens. Specimens from bronchoalveolar lavage (n = 39) and bronchial biopsies (n = 17), and peripheral blood leukocytes (n = 57) were examined. In peripheral blood leukocytes and bronchial biopsy specimens no CMV-positive cells were detected. The bronchoalveolar lavage analysis of two patients showed immediate early antigen-positive cells after 1 to 3 months. At the same time the patients had clinical symptoms that could also be related to lung rejection. Serologic conversion (CMV-IgM) occurred only 6 days later in one patient with informative follow-up analysis; CMV culture (available 4 to 6 weeks later) confirmed the diagnosis retrospectively. DHPG treatment was started immediately and resulted in CMV antigen negativity in bronchoalveolar lavage fluid after one or two courses (10 mg/kg/day; 14 days). Direct antigen detection offers a fast and specific monitoring of early CMV infection. The implications to the clinical management of lung transplant patients are discussed.
AuthorsG Steinhoff, M Behrend, T O Wagner, M H Höper, A Haverich (Affiliation: Center of Surgery and Internal Medicine, Medical School Hannover, F.R.G.)
JournalThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (J Heart Lung Transplant) 1991 Jan-Feb Vol. 10 Issue 1 Pt 1 Pg. 9-14 ISSN: 1053-2498 [Print] UNITED STATES
PMID1848789 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Viral
  • Ganciclovir
Topics
  • Adult
  • Antibodies, Monoclonal (diagnostic use)
  • Antigens, Viral (analysis)
  • Bronchoalveolar Lavage Fluid (cytology)
  • Cytomegalovirus (immunology)
  • Cytomegalovirus Infections (diagnosis, therapy)
  • Female
  • Ganciclovir (therapeutic use)
  • Heart-Lung Transplantation
  • Humans
  • Immunization, Passive
  • Lung Transplantation
  • Male
  • Pneumonia, Viral (diagnosis, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD